Chesnoy-Marchais D, Cathala L
Laboratoire de Neurobiologie Moléculaire et Cellulaire, CNRS UMR-8544, Ecole Normale Supérieure, 46 rue d'Ulm, 75005, Paris, France.
Eur J Neurosci. 2001 Jun;13(12):2195-204. doi: 10.1046/j.0953-816x.2001.01599.x.
Although glycine receptors (GlyRs) are responsible for the main spinal inhibitory responses in adult vertebrates, in the embryo they have been reported to mediate depolarizing responses, which can sometimes activate dihydropyridine-sensitive L-type calcium channels. However, these channels are not the only targets of dihydropyridines (DHPs), and we questioned whether GlyRs might be directly modulated by DHPs. By whole-cell recording of cultured spinal neurons, we investigated modulation of glycine responses by the calcium channel antagonists, nifedipine, nitrendipine, nicardipine and (R)-Bay K 8644, and by the calcium channel, agonist (S)-Bay K 8644. At concentrations between 1 and 10 microM, all these DHPs could block glycine responses, even in the absence of extracellular Ca2+. The block was stronger at higher glycine concentrations, and increased with time during each glycine application. Nicardipine blocked GABAA responses from the same neurons in a similar manner. In addition to their blocking effects, nitrendipine and nicardipine potentiated the peak responses to low glycine concentrations. Both effects of extracellular nitrendipine on glycine responses persisted when the drug was present in the intracellular solution. Thus, these modulations are related neither to calcium channel modulation nor to possible intracellular effects of DHPs. Another type of calcium antagonist, verapamil (10-50 microM), also blocked glycine responses. Our results suggest that some of the effects of calcium antagonists, including the neuroprotective and anticonvulsant effects of DHPs, might result partly from their interactions with ligand-gated chloride channels.
尽管甘氨酸受体(GlyRs)负责成年脊椎动物主要的脊髓抑制反应,但据报道,在胚胎中它们介导去极化反应,有时可激活对二氢吡啶敏感的L型钙通道。然而,这些通道并非二氢吡啶(DHPs)的唯一靶点,我们质疑GlyRs是否可能直接受到DHPs的调节。通过对培养的脊髓神经元进行全细胞记录,我们研究了钙通道拮抗剂硝苯地平、尼群地平、尼卡地平、(R)-Bay K 8644以及钙通道激动剂(S)-Bay K 8644对甘氨酸反应的调节作用。在1至10微摩尔的浓度范围内,即使在没有细胞外Ca2+的情况下,所有这些DHPs均可阻断甘氨酸反应。在较高的甘氨酸浓度下,阻断作用更强,并且在每次施加甘氨酸的过程中随时间增加。尼卡地平以类似的方式阻断来自相同神经元的GABAA反应。除了阻断作用外,尼群地平和尼卡地平还增强了对低浓度甘氨酸的峰值反应。当药物存在于细胞内溶液中时,细胞外尼群地平对甘氨酸反应的这两种作用仍然存在。因此,这些调节作用既与钙通道调节无关,也与DHPs可能的细胞内作用无关。另一种类型的钙拮抗剂维拉帕米(10 - 50微摩尔)也可阻断甘氨酸反应。我们的结果表明,包括DHPs的神经保护和抗惊厥作用在内的一些钙拮抗剂的作用,可能部分源于它们与配体门控氯离子通道的相互作用。